MTOR and cancer: Moreover, several studies investigated the efficacy of combining mTOR inhibitors with mimic miRNAs in cancer cell models, and microRNA-driven mTOR modulation might have therapeutic benefit increasing sensitivity not only to rapamicin analogs but also to different anticancer drugs such as doxorubicin, cisplatin and taxanes [15, 18, 19].